Skip to content

An Open-Label Phase II Clinical Study on the Safety and Efficacy of Siddha Drug Indhuppu Bhavanai for Treating Eri Gunmam (Acid Peptic Disease)

Single centric Open Clinical trial Phase II in Eri gunmam (Acid Peptic Disease) with siddha medicine Indhuppu bhavanai - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105929
Enrollment
44
Registered
2026-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K259- Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: INDHUPPU BHAVANAI: Purified indhuppu -5 PALAM (175 grams) Vallarai chaaru (centella asiatica juice) Yelumichai chaaru (lemon juice) Inji chaaru (Ginger juice) Nellikai chaaru (Amla juic

Sponsors

Dr M Shilpa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a clinical diagnosis of acid peptic disease (inclunding gastritis gastric ulcer or duodenal ulcer) confirmed by history and/or endoscopy (if applicable) presence of moderate to severe gastrointestinal symptoms relevant to APD as per GSRS domains (reflex abdominal pain, indigestion, diarrhoea, constipation)

Exclusion criteria

Exclusion criteria: Malignancy, cases of acute proble, volnerable population, hypertension

Design outcomes

Primary

MeasureTime frame
It is mainly assessed by the reduction in clinical symptoms mentioned in GSRS scale ( heart burn, pain abdomen, nausea, vomiting, bloating )Timepoint: 48 days

Secondary

MeasureTime frame
It is mainly assessed by the reduction in clinical symptoms mentioned in GSRS scale ( heart burn, pain abdomen, nausea, vomiting, bloating )Timepoint: 48 days

Countries

India

Contacts

Public ContactDr R MENAKA

GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026